MyMeds&Me is a company within Qinecsa Solutions, offering end-to-end pharmacovigilance solutions to simplify adverse event capture. Founded in 2012 by Senior Pharma executives, the company aims to accelerate safety insights through digital transformation. MyMeds&Me's Reportum platform is a scalable drug safety platform for the capture, management & processing of adverse events & product quality complaints.
The company operates in industries such as Biopharma, Biotechnology, Pharmaceutical and is based in the United Kingdom. At present, there is no available information on the last investment or the investors involved in the last investment.
To learn more, visit their website at mymedsandme.com.
There is no investment information
No recent news or press coverage available for MyMeds&Me.